SHMLF 20-F DEF-14A Report Dec. 31, 2022

SHL TELEMEDICINE LTD

20-Fs

20-F	Fiscal year ended Dec. 31, 2024
20-F	Fiscal year ended Dec. 31, 2023
20-F	Fiscal year ended Dec. 31, 2022

Name: SHL TELEMEDICINE LTD CIK: 1166834 Filing Type: 20-F/A Report Date: 2022-12-31 Download URL: https://www.sec.gov/Archives/edgar/data/1166834/000110465923060008/shlt-20221231x20f.htm

TABLE OF CONTENTS

Part I Item 1. Identity Of Directors, Senior Management and Advisers Item 2. Offer Statistics and Expected Timetable Item 3. Key Information Item 4. Information on The Company Item 4. A.unresolved Staff Comments Item 5. Operating and Financial Review and Prospects Item 6. Directors, Senior Management and Employees Item 7. Major Shareholders and Related Party Transactions Item 8. Financial Information Item 9. The Offer and Listing Item 10. Additional Information Item 11. Quantitative and Qualitative Disclosures About Market Risk Item 12. Description Of Securities Other Than Equity Securities Part II Item 13. Defaults, Dividend Arrearages and Delinquencies Item 14. Material Modifications To The Rights Of Security Holders and Use Of Proceeds Item 15. Controls and Procedures Item 16. [reserved]Item 16. A.audit Committee Financial Expert Item 16. A Item 16. B.code Of Ethics Item 16. B Item 16. C.principal Accountant Fees and Services Item 16. C Item 16. D.exemptions From The Listing Standards For Audit Committees Item 16. D Item 16. E.purchases Of Equity Securities By The Issuer and Affiliated Purchasers Item 16. E Item 16. F.change in Registrant S Certified Accountant Item 16. F Item 16. G.corporate Governance Item 16. G Item 16. H.mine Safety Disclosure Item 16. H Item 16. I.disclosure Regarding Foreign Jurisdictions That Prevent Inspections Item 16. I Item 16J. Insider Trading Policies Part III Item 17. Financial Statements Item 18. Financial Statements Item 19. Exhibits Note 1:-general Note 2:-significant Accounting Policies Note 2:-significant Accounting Policies (cont.)Note 3:-significant Accounting Judgments, Estimates and Assumptions Used in Preparation Of The Financial Statements Note 3:-significant Accounting Judgments, Estimates and Assumptions Used in Preparation Of The Financial Statements (cont.)Note 4:-disclosure Of New Standards in The Period Prior To Their Adoption Note 4:-disclosure Of New Standards in The Period Prior To Their Adoption (cont.)Note 5:-acquisition Of Subsidiaries Note 5:-acquisition Of Subsidiaries (cont.)Note 6:-cash and Cash Equivalents Note 7:-short-term Investments Note 8:-trade Receivables Note 9:-prepaid Expenses Note 10:-other Accounts Receivable Note 11:-property and Equipment Note 12:-goodwill and Intangible Assets, Net Note 12:-goodwill and Intangible Assets, Net (cont.)Note 13:-leases Note 13:-leases (cont.)Note 14:-credit From Banks Note 15:-long-term Loans Note 16:-deferred Revenues Note 17:-other Payables Note 18:-financial Instruments Note 18:-financial Instruments (cont.)Note 19:-employee Benefit Liabilities Note 19:-employee Benefit Liabilities (cont.)Note 20:-taxes on Income Note 20:-taxes on Income (cont.)Note 21:-compensation Of Key Management Personnel (including Directors)Note 22:-commitments and Contingent Liabilities Note 23:-equity Note 23:-equity (cont.)Note 24:- Supplementary Information To Statements Of Comprehensive Income Note 24:- Supplementary Information To Statements Of Comprehensive Income (cont.)Note 25:- Net Earnings Per Share Note 26:- Segment Information Note 26:- Segment Information (cont.)Note 27:- Subsequent Events

Exhibits

1.1* Articles of Association of the Registrant. 2.1* Formof Deposit Agreement among the Registrant, The Bank of New York Mellon, as Depositary, and all Owners and Holders from time to time of American Depositary Shares issued thereunder. 2.2* Formof Registrants American Depositary Receipt (included as ExhibitA to Exhibit2.1). 2.3 Description of the Registrants securities registered under Section12 of the Exchange Act. 4.1* 2021 Executive and Key Employee Israeli Share Incentive Plan. 4.2* Share Purchase Agreement, dated August25, 2021, among the Registrant, Mediton Medical Centers ChainLtd. and MedishurLtd.** 4.3* Amendment No.1 to Share Purchase Agreement, dated December20, 2021, among the Registrant, Mediton Medical Centers ChainLtd. and MedishurLtd.** 4.4* Consulting (Services) Agreement, dated August2, 2020, by and between the Registrant and Mr.Erez Nachtomy. 4.5* First Amendment to the Consulting (Services) Agreement, dated June29, 2022, by and between the Registrant and Mr.Erez Nachtomy. 4.6* Service Terms of Co-Chairman for the Registrant for Ehud Barak. 4.7* Consulting Agreement dated July1, 2020, by and between the Registrant and Irit Alroy. 8.1* Subsidiaries of the Registrant. 11.1 Code of Ethics of the Registrant. 12.1 CEO Certification Pursuant to Section302 of the Sarbanes Oxley Act of 2002 12.2 CFO Certification Pursuant to Section302 of the Sarbanes Oxley Act of 2002 13.1# CEO Certification Pursuant to Section906 of the Sarbanes Oxley Act of 2002 13.2# CFO Certification Pursuant to Section906 of the Sarbanes Oxley Act of 2002

SHMLF 20-F Report ended Dec. 31, 2022

Exhibits